43rd Annual Southeastern Consortium for Dermatology
October 4 – 6, 2019
Durham Convention Center | Durham, NC
Hosted by Duke University
Meeting Handouts & Disclosures
Click any one the following links to download handout:
Friday, October 4
1:00 pm Cutting Edge Treatment of HS Now and in the Future
1:30 pm Update on Melanoma
2:00 pm Psoriasis: Which Drug to Choose When
2:30 pm Advances in the Treatment of Autoimmune Blistering Diseases
3:30 pm Pedicures, Lasers, and other Mycobabacterial Adventures
4:00 pm Clinical Pearls and Tips for HPV/Condyloma
4:30 pm Short Term Experiences in Global Health (STEGHs): Myths, Realities, and Infections
5:00 pm Dermatopathology of Infectious Diseases
Saturday, October 5
8:00 am Pathological Assessment of Hair Loss
8:25 am Pre-JAK Inhibitors: What Works and What Doesn’t
8:50 am To Come – New Thoughts on Etiology Factors for Alopecia Areata (Lund Lecturer)
9:35 am To Come – JAK Inhibitors for Alopecia Areata
10:40 am Evaluation and Management of Female Pattern Hair Loss
11:05 am Frontal Fibrosing Alopecia, PRP and Microneedling
11:35 am Update in Central Centrifugal Cicatricial Alopecia
12:05 pm To Come – Future Directions in Male and Female Pattern Hair Loss (Callaway Lecturer)
Summary of Faculty Disclosures/Planning Committee
The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity: Angela Christiano, PhD; Dirk Elston, MD; MHS; Russell Hall, MD; Tiffany Mayo, MD; Elise Olsen, MD; Samantha Wennerberg, PA; Sarah Wolfe, MD; Carrie Kovarik, MD; Benjamin Stoff, MD, MA; Jason Stout, MD; Abby Van Voorhees, MD
The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:
George Cotsarelis, MD has indicated that he is on the Advisory Board for Follica.
James Grichnik, MD has indicated that he is a stockholder of DigitalDerm.
Amy McMichael, MD has indicated that she receives royalties from Informa Healthcare
Chris Sayed, MD has indicated that he is a speaker for Abbvie and Novartis.
Jerry Shapiro, MD is on the Advisory Board for Incyte and Aclaris, and a stockholder of Replicel.